Ellen Costello - 17 May 2022 Form 4 Insider Report for DIEBOLD NIXDORF, Inc (DBD)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
17 May 2022, 16:07:07 UTC
Prior SEC filing
12 May 2022
Next SEC filing
06 Jul 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Jonathan B. Leiken, Attorney-in-fact for Ellen M. Costello

Key filing fact

Ellen Costello filed Form 4 for DIEBOLD NIXDORF, Inc (DBD) on 17 May 2022.

Key facts

  • This page summarizes Ellen Costello's Form 4 filing for DIEBOLD NIXDORF, Inc (DBD).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 May 2022, 16:07.

Change

  • Previous filing in this sequence was filed on 12 May 2022.
  • Current net transaction value: +$39,480.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DBD transaction

Common Shares

Purchase

Transaction value
$39,480
Shares
+12,000
Change %
+7.8%
Price
$3.29*
Shares after
166,283
Date
17 May 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Number includes Deferred Shares.

Footnote F2

Number includes restricted stock units.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .